|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Lung cancer显示文摘 | Hoffman PC Mauer AM Vokes EE | | 0，，9202： | 1 |
| 2 | A phase Ⅱ study of oxaliplatin and paclitaxel in patients with advanced non-small cell lung cancer显示文摘 | Winegarden JD Mauer AM Otterson GA | 2004 | Ann Oncol2004，15，： | 1 |
| 3 | A phase Istudy of pemetrexed,carboplatin, and concurrent radio-therapy inpatients with locally advanced or metastatic non-small cell lung or esophageal cancer显示文摘 | Seiwert TY Connell PP Mauer AM | 2007 | Clin Cancer Res2007，13，21： | 1 |
| 4 | A phase Ⅱ study of oxaliplatin and paclitaxel in patients with advanced non - small- cell lung cancer显示文摘 | Winegarden JD Mauer AM Otterson GA etal | 2004 | Ann Oncol2004，15，6： | 1 |
| 5 | Lung cancer 显示文摘 | Hoffman PC Mauer AM Vokes EE | 2000 | Lancet2000，355，9202： | 1 |
| 6 | Phase Ⅱ study of oxaliplatin (OX), fluorouracil(FU) and leucovorin(LV) in metastatic carcinoma of the esophagus/gastric cardia显示文摘 | Mauer AM Kraut E H RudinCM | 2002 | Proc Am Soc Clin Oncol2002，21，15： | 1 |
| 7 | A phase I study of erlotinib and bevacizumab for recurrent or metastatic squamous cell carcinoma of the head and neck(HNC)显示文摘 | Vokes EE Cohen EE Mauer AM | 2005 | J Clin Oncol2005，23，16： | 1 |
| 8 | A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer显示文摘 | Kim ES Mauer AM Jr William WN | | 0，，08： | 1 |
| 9 | Phase I study of epidermal growth factor receptor (EGFR) inhibitor, erlotinib, and vascular endothelial growth factor monoclonal antibody, bevacizumab, in recurrent and/or metastatic squamous cell carcinoma of the head and neck(SCCHN) 显示文摘 | Mauer AM Cohen EEW Wong SJ | 2004 | Proc Am Soc Clin Oncol2004，23，： | 1 |
| 10 | Phase II trial of oxaliplatin,leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus显示文摘 | Mauer AM Kraut EH Krauss SA | 2005 | Ann Oncol2005，16，8： | 1 |
| 11 | Lung cancer显示文摘 | Hoffillan PC Mauer AM Yokes EE | 2000 | Lancet2000，355，9202： | 1 |
| 12 | A phase I study of pem-etrexed ,carboplatin, and concurrent radiotherapy in patientswith locally advanced or metastatic non-small cell lung or e-sophageal cancer 显示文摘 | Seiwert TY Connell PP Mauer AM | 2007 | Clin Cancer Res2007，13，21： | 1 |
| 13 | Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment 显示文摘 | Mehta N Mauer AM Hellman S | 2004 | Int J Oncol2004，25，6： | 1 |
| 14 | Phase Ⅱ trial of oxaliplatin,leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus显示文摘 | Mauer AM Kraut EH Krauss SA | 2005 | Ann Oncol2005，16，8： | 1 |
| 15 | A phase I study of peme- trexed, carboplatin, and conncurrent radiotherapy in patients with lacally advanced or metastatic non-small cell lung or esophageal cancer 显示文摘 | Seiwert TY Connell PP Mauer AM | 2007 | Clin Cancer Res2007，13，21： | 1 |
| 16 | A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer 显示文摘 | Rudin CM Otterson GA Mauer AM | 2002 | Ann Oncol2002，13，4： | 1 |
| 17 | A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer显示文摘 | Kim ES Mauer AM William WN Jr | 2009 | Cancer2009，115，8： | 1 |
| 18 | Phase Ⅱ trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus 显示文摘 | Mauer AM Kraut EH Krauss SA | 2005 | Annals of Oncology2005，16，8： | 1 |
| 19 | A phase n study of oxaliplatin and paclitaxel with advanced non -small cell lung cancer 显示文摘 | Winegarden TD Mauer AM Otterson GA | 2004 | Ann Oncol2004，15，6： | 1 |
| 20 | Lung cancer显示文摘 | Hoffman PC Mauer AM Vokes EE | 2000 | Lancet2000，355，9202： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员